Concepedia
Statistics
Publications
6
Citations
312
H-Index
Active since
2006
Affiliations
Inserm(Current)
Institut Gustave Roussy
Chinese Academy of Sciences
Institute of Zoology
Institut Curie
Franck Meslin is an author at Inserm specializing in oncology, cancer cell signaling, and signal transduction.
Publications per year
2006–2008
ICAM-1 Has a Critical Role in the Regulation of Metastatic Melanoma Tumor Susceptibility to CTL Lysis by Interfering with PI3K/AKT Pathway
Ahmed Hamaï, Franck Meslin, Houssem Benlalam et al. · Cancer Research · 2008 · 81 citations
Medicine, Immunology, Oncology +17
Silencing of Prion Protein Sensitizes Breast Adriamycin-Resistant Carcinoma Cells to TRAIL-Mediated Cell Death
Franck Meslin, Ahmed Hamaï, Ping Gao et al. · Cancer Research · 2007 · 66 citations · Full text
Life Sciences, Oncology, Pharmacology +17
Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation
Ahmed Hamaï, Catherine Richon, Franck Meslin et al. · Oncogene · 2006 · 52 citations
Life Sciences, Cell Biology, Oncology +16
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer
Franck Meslin, Rosa Conforti, Chafika Mazouni et al. · Annals of Oncology · 2007 · 42 citations · Full text
Medicine, Oncology, Pharmacology +15
Granzyme B-induced Cell Death Involves Induction of p53 Tumor Suppressor Gene and Its Activation in Tumor Target Cells
Franck Meslin, Jérôme Thiery, Catherine Richon et al. · Journal of Biological Chemistry · 2007 · 37 citations · Full text
Life Sciences, Immunology, Oncology +16
1–5 of 6